• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cleavage efficiency of CRISPR/Cas9 system with G-quadruplex-capped single-guide RNA motifs in RNase II and RNase R.具有G-四链体封端单导向RNA基序的CRISPR/Cas9系统在核糖核酸酶II和核糖核酸酶R中的切割效率
3 Biotech. 2025 Jun;15(6):189. doi: 10.1007/s13205-025-04354-x. Epub 2025 May 26.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
Harnessing an anti-CRISPR protein for powering CRISPR/Cas9-mediated genome editing in undomesticated Bacillus strains.利用一种抗CRISPR蛋白在未驯化的芽孢杆菌菌株中推动CRISPR/Cas9介导的基因组编辑。
Microb Cell Fact. 2025 Jun 23;24(1):143. doi: 10.1186/s12934-025-02776-z.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Single-incision sling operations for urinary incontinence in women.女性尿失禁的单切口吊带手术
Cochrane Database Syst Rev. 2017 Jul 26;7(7):CD008709. doi: 10.1002/14651858.CD008709.pub3.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
10
Incentives for preventing smoking in children and adolescents.预防儿童和青少年吸烟的激励措施。
Cochrane Database Syst Rev. 2012 Oct 17;10:CD008645. doi: 10.1002/14651858.CD008645.pub2.

本文引用的文献

1
Gene editing by SSB/CRISPR-Cas9 ribonucleoprotein in bacteria.细菌中 SSB/CRISPR-Cas9 核糖核蛋白的基因编辑。
Int J Biol Macromol. 2024 Oct;278(Pt 4):135065. doi: 10.1016/j.ijbiomac.2024.135065. Epub 2024 Aug 24.
2
Application and progress of CRISPR/Cas9 gene editing in B-cell lymphoma: a narrative review.CRISPR/Cas9基因编辑在B细胞淋巴瘤中的应用与进展:一项叙述性综述
Transl Cancer Res. 2024 Mar 31;13(3):1584-1595. doi: 10.21037/tcr-23-1146. Epub 2024 Mar 14.
3
Application of CRISPR/Cas9 for targeted mutagenesis in teosinte Zea mays ssp. parviglumis.CRISPR/Cas9在玉米小颖野生种(Zea mays ssp. parviglumis)中用于靶向诱变的应用。
Plant Biotechnol J. 2024 Apr;22(4):796-798. doi: 10.1111/pbi.14269. Epub 2023 Dec 12.
4
CRISPR/Cas9-gene editing approaches in plant breeding.植物育种中的 CRISPR/Cas9 基因编辑方法。
GM Crops Food. 2023 Dec 31;14(1):1-17. doi: 10.1080/21645698.2023.2256930. Epub 2023 Sep 19.
5
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction.CRISPR/Cas9 技术在癌症治疗中的应用:未来方向。
Curr Oncol. 2023 Feb 6;30(2):1954-1976. doi: 10.3390/curroncol30020152.
6
CRISPR/Cas9 therapeutics: progress and prospects.CRISPR/Cas9 疗法:进展与展望。
Signal Transduct Target Ther. 2023 Jan 16;8(1):36. doi: 10.1038/s41392-023-01309-7.
7
G-quadruplex-guided RNA engineering to modulate CRISPR-based genomic regulation.基于 G-四链体引导的 RNA 工程来调节基于 CRISPR 的基因组调控。
Nucleic Acids Res. 2022 Oct 28;50(19):11387-11400. doi: 10.1093/nar/gkac870.
8
Enhancing prime editing efficiency by modified pegRNA with RNA G-quadruplexes.通过带有RNA G-四链体的修饰pegRNA提高碱基编辑效率。
J Mol Cell Biol. 2022 Aug 2;14(4). doi: 10.1093/jmcb/mjac022.
9
Applications of CRISPR/Cas9 technology for modification of the plant genome.CRISPR/Cas9 技术在植物基因组修饰中的应用。
Genetica. 2022 Feb;150(1):1-12. doi: 10.1007/s10709-021-00146-2. Epub 2022 Jan 12.
10
Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells.化学修饰的向导 RNA 增强了 CRISPR-Cas13 在人细胞中的敲低。
Cell Chem Biol. 2022 Feb 17;29(2):321-327.e4. doi: 10.1016/j.chembiol.2021.07.011. Epub 2021 Aug 2.

具有G-四链体封端单导向RNA基序的CRISPR/Cas9系统在核糖核酸酶II和核糖核酸酶R中的切割效率

Cleavage efficiency of CRISPR/Cas9 system with G-quadruplex-capped single-guide RNA motifs in RNase II and RNase R.

作者信息

Dang Dung Thanh

机构信息

Division of Physics and Applied Physics, SPMS, Nanyang Technological University, Singapore, Singapore.

Faculty of Biotechnology, Ho Chi Minh City Open University, HCM City, Vietnam.

出版信息

3 Biotech. 2025 Jun;15(6):189. doi: 10.1007/s13205-025-04354-x. Epub 2025 May 26.

DOI:10.1007/s13205-025-04354-x
PMID:40438159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12106176/
Abstract

UNLABELLED

Modification of sgRNA has been considered as a necessary approach to enhance the stability and cleavage efficiency of the CRISPR/Cas9 system. In this study, a rigid G-quadruplex structure was genetically applied to the 3' end of typical sgRNA for protection of RNA from 3'-5' exoribonuclease degradation. The transcriptional production yields of sgRNAs bearing G-quadruplex structure such as sgRNA3 and sgRNA4 were around 1.4 and 1.5 times higher than the yield of typical sgRNA1, respectively. The results have also shown that appending G-quadruplex motif at the 3' end of typical sgRNAs did minorly affect the cleavage activity of CRISPR/Cas9. Interestingly, cleavage efficiency of CRISPR/Cas9 system with sgRNAs bearing the rigid G-quadruplex was fully retained in the presence of 3'-5' exoribonucleases such as RNase II or RNase R. In contrast, the cleavage activity of CRISPR/Cas9 system with the typical sgRNA1 was significantly decreased in the same condition. This protection of sgRNA through G-quadruplex structure-based modifications might provide a potential approach for improving cleavage efficiency of CRISPR/Cas9 system in the exoribonuclease environment.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s13205-025-04354-x.

摘要

未标记

对单向导RNA(sgRNA)进行修饰被认为是提高CRISPR/Cas9系统稳定性和切割效率的必要方法。在本研究中,一种刚性G-四链体结构被基因工程应用于典型sgRNA的3'端,以保护RNA不被3'-5'外切核糖核酸酶降解。带有G-四链体结构的sgRNA(如sgRNA3和sgRNA4)的转录产量分别比典型sgRNA1的产量高约1.4倍和1.5倍。结果还表明,在典型sgRNA的3'端附加G-四链体基序对CRISPR/Cas9的切割活性影响较小。有趣的是,在存在3'-5'外切核糖核酸酶(如核糖核酸酶II或核糖核酸酶R)的情况下,带有刚性G-四链体的sgRNA的CRISPR/Cas9系统的切割效率完全保留。相比之下,在相同条件下,典型sgRNA1的CRISPR/Cas9系统的切割活性显著降低。通过基于G-四链体结构的修饰对sgRNA的这种保护可能为提高外切核糖核酸酶环境中CRISPR/Cas9系统的切割效率提供一种潜在方法。

补充信息

在线版本包含可在10.1007/s13205-025-04354-x获取的补充材料。